Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan 13:2022:7097189.
doi: 10.1155/2022/7097189. eCollection 2022.

Remission of Suicidal Ideation in Emotionally Unstable Personality Disorder with Flupenthixol

Affiliations
Case Reports

Remission of Suicidal Ideation in Emotionally Unstable Personality Disorder with Flupenthixol

Daniel J Chivers et al. Case Rep Psychiatry. .

Abstract

There are currently no licensed pharmacological treatments for Emotionally Unstable Personality Disorder. This case report describes a 50-year-old male who two years previously had been brought to the attention of psychiatric services following an overdose with intention to end his life. He was subsequently diagnosed with Emotionally Unstable Personality Disorder (EUPD) and, following further suicide attempts and trials of mainstream pharmacological treatments, responded to flupenthixol IM 20 mg fortnightly, experiencing complete remission from his suicidal ideation. Clinicians should be aware of EUPD presenting in later life and should consider the role of typical antipsychotics, including flupenthixol, in the treatment of suicidal ideation in patients with EUPD. Age-specific guidance on EUPD management would be of use to clinicians, especially in the management of older patients, as current guidance is based on findings within a narrow age group.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. World Health Organisation. International Statistical Classification of Diseases and Related Health Problems . 11th ed. ICD-11; World Health Organization; 2019.
    1. Biskin R. S. The lifetime course of borderline personality disorder. Canadian Journal of Psychiatry . 2015;60(7):303–308. doi: 10.1177/070674371506000702. - DOI - PMC - PubMed
    1. Battaglia J., Wolff T. K., Wagner-Johnson D. S., Rush A. J., Carmody T. J., Basco M. R. Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department. International Clinical Psychopharmacology . 1999;14(6):361–372. doi: 10.1097/00004850-199911000-00007. PMID: 10565804. - DOI - PubMed
    1. Javed Q., Chorghade A., Javed S., Pervez Y. Reduction in self-harming behaviour after zuclopenthixol decanoate. Progress in Neurology and Psychiatry . 2014;18(4):23–27. doi: 10.1002/pnp.340. - DOI
    1. Stoffers J., Völlm B. A., Rücker G., et al. Pharmacological interventions for borderline personality disorder. Cochrane Database of Systematic Reviews . 2010;6 doi: 10.1002/14651858.CD005653.pub2. - DOI - PMC - PubMed

Publication types

LinkOut - more resources